Lyne Fortin Insider Profile
4 Followers
Lyne Fortin, former Chief Commercial Officer at Theratechnologies, holds 200.00K shares in Small Pharma (Ticker: TSE:DMT), holds 11.31K shares in Theratechnologies (Ticker: THTX). Most recently, Lyne Fortin Bought ― shares of Small Pharma on Jul 29, 2022 for an estimated value of C$12.01K.
Lyne Fortin's Trading History
| DMTSmall Pharma | Jul 29, 2022 | ― | Informative Buy | 12.01K | C$32.00K | |
| THTXTheratechnologies | Oct 10, 2018 | ― | Informative Sell | 115.13K | $38.34K |
You May Also Like
Lyne Fortin insider profile FAQ
What is the percentage of profitable transactions made by Lyne Fortin?
The percentage of profitable transactions made by Lyne Fortin is 60%.
What is the average return per transaction made by Lyne Fortin?
The average return per transaction made by Lyne Fortin is 9.00%.
What stocks does Lyne Fortin hold?
Lyne Fortin holds: THTX, TSE:DMT stocks.
What was Lyne Fortin’s latest transaction?
Lyne Fortin’s latest transaction was an Informative Buy of C$12.01K.
What was Lyne Fortin's most profitable transaction?
Lyne Fortin’s most profitable transaction was an Informative Buy of THTX stock on December 8, 2016. The return on the trade was 132.50%.
What is Lyne Fortin's role in Theratechnologies?
Lyne Fortin's role in Theratechnologies is Chief Commercial Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
